Advances in the associated study of cardiovascular disease with depression and anxiety in general hospitals

Cardiovascular disease (CVD) has high incidence and fatality rate in general hospitals, and its risk factors and disease prevention have been the focus of research. In recent years, because of the important influence of psychological factors, such as depression anxiety on CVD patients, psychological factors as controllable factors have become the focus of research. Depression and anxiety can increase the incidence of CVD. People with depression and anxiety are likely to develop CVD than normal. Depression and anxiety can exacerbate adverse consequences of CVD, such as increased fatality. Patients with CVD can also develop depression and anxiety. For patients with CVD, the occurrence of depression and anxiety is related to various factors. For example, disease-related events can be used as a stress factor to cause depression and anxiety. During the recovery period of the disease, different levels of physical activity, quality of life and other possible cognitive impairment can also be associated with depression and anxiety. Psychological therapy and drug therapy can be considered as treatment for CVD patients combined with depression and anxiety. Given the effectiveness and safety of psychotherapy, it has also become a trend of treatment in recent years, but the specific form of implementation should be based on a specific situation. For medications, the use of anti-depressants, such as selective serotonin reuptake inhibitors, can significantly improve depression and anxiety and reduce the risk of cardiovascular events. However, inappropriate drug use may also increase the risk of CVD. Therefore, the use of drugs must be scientifically evaluated, carefully selected and correctly applied.